KineMed Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 53
Employees
  • Latest Deal Type
  • Bankr. Admin/​Reorg

KineMed General Information

Description

Provider of drug development life cycle services. The company provides drug development services including candidate selection, human studies, proof of concept studies, efficacy studies and post launch studies.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 5980 Horton Street
  • Suite 470
  • Emeryville, CA 94608
  • United States
+1 (510) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KineMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Bankruptcy: Admin/Reorg 05-Apr-2016 Completed Bankruptcy: Admin/Reorg
11. Later Stage VC 07-Jul-2015 00.000 000.00 Completed Generating Revenue
10. Debt - General 01-Dec-2014 000 000.00 Completed Generating Revenue
9. IPO 24-Jul-2014 0000 00000 Cancelled Generating Revenue
8. Later Stage VC (Series CC) 10-Jan-2014 00.00 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 12-Dec-2012 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series BB) 09-Nov-2011 00.000 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series AA) 07-Jan-2010 00.000 000.00 000.00 Completed Generating Revenue
4. Debt - General 03-Aug-2007 $15M $36.4M Completed Startup
3. Later Stage VC (Series C) 01-Mar-2004 $10M $21.4M 000.00 Completed Startup
To view KineMed’s complete valuation and funding history, request access »

KineMed Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series CC 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series BB 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series AA 125,000,000 $0.001000 $0 $0.06 $0.06 1x $0.06 33.92%
To view KineMed’s complete cap table history, request access »

KineMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of drug development life cycle services. The company provides drug development services including candidate sel
Discovery Tools (Healthcare)
Emeryville, CA
53 As of 2014
000.00
0000000000.

00000000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
000000000 00000 (0000000000)
Nottingham, United Kingdom
000 As of 0000
0000000 0000

00000000

odo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
000000000 00000 (0000000000)
San Francisco, CA
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KineMed Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom 000 0000000 0000
00000000 Formerly VC-backed San Francisco, CA 00 000.00 000000&0 000.00
00 000000000000 Venture Capital-Backed Guilford, CT 00 0000 000000000 - 0000
000000000000 Private Equity-Backed London, United Kingdom 000 00000 0000000 0000 00000
To view KineMed’s complete competitors history, request access »

KineMed Executive Team (19)

Name Title Board Seat Contact Info
David Fineman Chief Executive Officer, Chairman of the Board & Director
James Burden JD Director & Corporate Counsel
Henry Settle Jr. Director
James Manuso Ph.D Director
Aimee Ellis Director of Human Resources
You’re viewing 5 of 19 executive team members. Get the full list »

KineMed Board Members (2)

Name Representing Role Since
Marc Hellerstein Ph.D KineMed Co-Founder and Chairman 000 0000
To view KineMed’s complete board members history, request access »

KineMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial